Description
Medical device containing magnesium peroxide (not less than 25% MgO₂) as an active substance, which releases oxygen into the gastrointestinal tract. This oxygen release is accompanied by a significant reduction of intestinal germs, which are present in high numbers in acute and chronic intestinal pathologies (dysbiosis).
Ozovit MP is therefore used in cases of gastrointestinal disorders caused by abnormal fermentation and putrefaction. Ozovit MP has proven effective as a preliminary disinfecting agent for the intestinal tract in cases of dysbiosis. For intestinal mycoses, specific antifungal treatment should precede the use of Ozovit MP, as its activity on fungi and protozoa has been shown to be cytostatic.
Ozovit is an osmotic saline laxative. Since the absorption of magnesium peroxide is difficult, it leads to water retention and an increase in water in the intestinal lumen. The intestinal contents become more voluminous, resulting in increased peristalsis.
Ozovit MP is indicated for occasional constipation and as an intestinal evacuant before diagnostic tests or specific therapeutic treatments.

Composition
100 g contain: 100 g of magnesium peroxide.

Directions for use
Adults: 1 to 3 scoops of powder in water or fruit juice, twice a day 1 hour after meals.
In case of severe diarrhea, reduce the dosage or stop treatment for 2-3 days. Then resume administration with a lower dosage.

Warnings
Ozovit MP should not be used for more than one week.
Do not take in case of kidney failure and intestinal obstruction (ileus). Do not take in case of known hypersensitivity to magnesium peroxide. Do not administer to children and adolescents. In rare cases, side effects such as severe diarrhea with intestinal cramps and electrolyte loss may occur. These can be avoided by reducing the dosage.
Interactions with other medications: in general, to avoid impairing absorption, an interval of 1-2 hours should be observed between the administration of Ozovit MP and the following substances: iron, tetracyclines, sodium fluoride, isoniazid, chlorpromazine, and digoxin.
As with other laxatives, prolonged intake of Ozovit MP can cause loss of water, potassium, and other salts, leading to disturbances in heart function and myasthenia. For this reason, the duration of administration should be limited to one week.

Format
100 g package.

Cod. B054